Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + alfentanil vs propofol + alfentanil for painless gastroenteroscopy
ChiCTR2400086777Phase 4Not yet recruiting
- Sponsor
- Hefei Second People's Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in None comparing Propofol + alfentanil, Remimazolam + alfentanil and Low-dose propofol + remimazolam + alfentanil (3 arms). Primary endpoints: Mean blood pressure and Occurrence of complications. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
remimazolampropofolalfentanil
Beyond the preview
Go deeper on ChiCTR2400086777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086777.